P1456: EARLY SAFETY AND CLINICAL COURSE OF PATIENTS WITH ACUTE MYELOID LEUKEMIA AND MEASURABLE RESIDUAL DISEASE RECEIVING GTA002, AN OFF-THE-SHELF, EX VIVO-CULTURED ALLOGENEIC NK CELL PREPARATION

ABSTRACT:

SUBMITTER: Heuser M 

PROVIDER: S-EPMC9429039 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature